We regularly receive inquiries from patients who have allegedly suffered serious instances of Pradaxa bleeding. We are pleased to see this litigation moving forward.
New York, New York (PRWEB) May 05, 2013
Pradaxa lawsuits continue to move forward in a federal litigation currently underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to the court’s website, the next Status Conference in the Pradaxa litigation has been scheduled for May 14th at 9:00 a.m. Court documents indicate that just over 550 claims have been filed in the litigation by alleged victims of Pradaxa bleeding. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“We regularly receive inquiries from patients who have allegedly suffered serious instances of Pradaxa bleeding. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to individuals who suffered life-threatening episodes of internal bleeding that may be associated with use of this blood thinner.
Pradaxa was approved by the U.S. Food & Drug Administration (FDA) in October 2010 to prevent strokes in patients with atrial fibrillation. According to a recent Reuters report, Pradaxa sales rose more than 11% last year, and passed the $1 billion threshold that denotes blockbuster status in the pharmaceutical industry.* Pradaxa was touted as an improvement over decades-old warfarin, but Bloomberg.com recently reported that regulators in several countries have issued alerts regarding the drug’s potential to cause dangerous internal bleeding in some patients. **
Among other things, there exists no readily-available antidote for the internal bleeding that can sometimes occur in patients treated with Pradaxa. In 2011 alone, the FDA received reports of 542 deaths and 3,781 side-effect incidents tied to Pradaxa, Bloomberg.com said. Earlier this year, the Institute for Safe Medicine Practices renewed concerns about Pradaxa bleeding, when it revealed that an analysis of hemorrhage cases reported to the FDA during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.***
Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. Additional information is available at Bernstein Liebhard LLP’s website, or by calling 1-877-779-1414 to speak with a Pradaxa lawyer today.
*reuters.com/article/2013/04/24/boehringer-results-idUSL6N0DB1WB20130424 (April 24, 2013)
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html (December 12, 2012)
***ismp.org/quarterwatch/pdfs/2012Q2.pdf (January 9, 2013)
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com